ISTO Tech Seeks Late-Stage VC, Eyes IPO
ISTO Technologies provides hope for anyone with knee injuries or back pain. ISTO, of St. Louis, has developed cell technology to help repair the cartilage of the knee, back or spine. Dr. Mitchell Seyedin, ISTO’s president and CEO, said the company will be looking for a late-stage investor, or mezzanine funding, later this year. Seyedin, who was speaking Thursday at the BMO Healthcare Conference in New York, didn’t disclose how much ISTO will be seeking. ISTO has raised $45 million through five rounds of funding, from Ascension Health Ventures, Alafi Capital, Life Sciences Partners, Mid-America Transplant Services and Zimmer Holdings.
6 August 2010•2 mins read
